| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.083 | 0.1 |